SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding
domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can …

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
highlights the urgent need for assays that detect protective levels of neutralizing antibodies …

Durability of SARS-CoV-2 Spike antibody responses after infection provides information
relevant to understanding protection against COVID-19 in humans. We report the results of a …

We measured plasma and/or serum antibody responses to the receptor-binding domain
(RBD) of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …

Serological and plasmablast responses and plasmablast-derived IgG monoclonal
antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical …

Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that
detect levels of neutralizing antibodies that may be protective. We studied the relationship …

BACKGROUND Serological assays are of critical importance to investigate correlates of
response and protection in coronavirus disease 2019 (COVID-19), to define previous …

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
around the world, there is an urgent need for new assay formats to characterize the humoral …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can
be detected indirectly by measuring the host immune response. For some viruses, antibody …

Antibodies serve as biomarkers of infection, but if sustained can confer long-term immunity.
Yet, for most clinically approved vaccines, binding antibody titers only serve as a surrogate …